FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605279665> ?p ?o ?g. }

• W2605279665 endingPage "445" @default.
• W2605279665 startingPage "437" @default.
• W2605279665 abstract "Metastasis is the key phase of cancer progression that characterizes a more advanced stage and a poorer prognosis. The majority of cancer fatalities occur as a consequence of metastasis. Mifepristone (RU486), a chemical abortifacient, has recently been used in clinical trials for psychotic depression and cancer chemotherapy. As the most predominant biological active metabolite of mifepristone, metapristone is being developed as a novel cancer metastasis chemopreventive agent by us. However, there is no information available to address the effects of metapristone on non-small cell lung cancer (NSCLC). The aim of our study was to investigate the inhibitory effect of metapristone on the proliferation and metastasis of NSCLC cells. In the present study, we evaluated the efficacy of metapristone on the growth, migration and invasion in different kinds of NSCLC cells (A549, H1975 and H1299), and further investigated the underlying mechanism of metapristone by real time PCR and western blot assay. Metapristone could significantly inhibit the proliferation, migration and invasion of NSCLC cells through suppressing RAS/RAF/MEK/MAPK and PI3K/AKT signaling pathways. Moreover, metapristone could effectively inhibit the formation of NSCLC cells’ cytoskeleton in a concentration-dependent manner, which possibly led to the inhibition of NSCLC cells’ migration. Overall, it was preliminarily demonstrated that metapristone could be developed as a useful agent to show anti-metastasis activity for NSCLC." @default.
• W2605279665 created "2017-04-14" @default.
• W2605279665 creator A5004759661 @default.
• W2605279665 creator A5042194405 @default.
• W2605279665 creator A5060165452 @default.
• W2605279665 creator A5060332213 @default.
• W2605279665 creator A5064455541 @default.
• W2605279665 creator A5075292463 @default.
• W2605279665 creator A5080466468 @default.
• W2605279665 date "2017-06-01" @default.
• W2605279665 modified "2023-10-13" @default.
• W2605279665 title "Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway" @default.
• W2605279665 cites W1899552912 @default.
• W2605279665 cites W1905492335 @default.
• W2605279665 cites W1913371122 @default.
• W2605279665 cites W1967828043 @default.
• W2605279665 cites W1975377745 @default.
• W2605279665 cites W1981815345 @default.
• W2605279665 cites W1989343897 @default.
• W2605279665 cites W2004280628 @default.
• W2605279665 cites W2021271765 @default.
• W2605279665 cites W2049361628 @default.
• W2605279665 cites W2057025738 @default.
• W2605279665 cites W2059401506 @default.
• W2605279665 cites W2061658883 @default.
• W2605279665 cites W2062249523 @default.
• W2605279665 cites W2091610671 @default.
• W2605279665 cites W2095554214 @default.
• W2605279665 cites W2102675992 @default.
• W2605279665 cites W2126274176 @default.
• W2605279665 cites W2151336238 @default.
• W2605279665 cites W2163798887 @default.
• W2605279665 cites W2172255378 @default.
• W2605279665 cites W2235523093 @default.
• W2605279665 cites W2522678042 @default.
• W2605279665 cites W2917837889 @default.
• W2605279665 doi "https://doi.org/10.1016/j.biopha.2017.03.091" @default.
• W2605279665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28391165" @default.
• W2605279665 hasPublicationYear "2017" @default.
• W2605279665 type Work @default.
• W2605279665 sameAs 2605279665 @default.
• W2605279665 citedByCount "25" @default.
• W2605279665 countsByYear W26052796652017 @default.
• W2605279665 countsByYear W26052796652018 @default.
• W2605279665 countsByYear W26052796652019 @default.
• W2605279665 countsByYear W26052796652020 @default.
• W2605279665 countsByYear W26052796652021 @default.
• W2605279665 countsByYear W26052796652022 @default.
• W2605279665 countsByYear W26052796652023 @default.
• W2605279665 crossrefType "journal-article" @default.
• W2605279665 hasAuthorship W2605279665A5004759661 @default.
• W2605279665 hasAuthorship W2605279665A5042194405 @default.
• W2605279665 hasAuthorship W2605279665A5060165452 @default.
• W2605279665 hasAuthorship W2605279665A5060332213 @default.
• W2605279665 hasAuthorship W2605279665A5064455541 @default.
• W2605279665 hasAuthorship W2605279665A5075292463 @default.
• W2605279665 hasAuthorship W2605279665A5080466468 @default.
• W2605279665 hasBestOaLocation W26052796651 @default.
• W2605279665 hasConcept C121608353 @default.
• W2605279665 hasConcept C126322002 @default.
• W2605279665 hasConcept C143998085 @default.
• W2605279665 hasConcept C2776256026 @default.
• W2605279665 hasConcept C2778826759 @default.
• W2605279665 hasConcept C2779013556 @default.
• W2605279665 hasConcept C2779234561 @default.
• W2605279665 hasConcept C502942594 @default.
• W2605279665 hasConcept C54355233 @default.
• W2605279665 hasConcept C57074206 @default.
• W2605279665 hasConcept C62112901 @default.
• W2605279665 hasConcept C62478195 @default.
• W2605279665 hasConcept C71924100 @default.
• W2605279665 hasConcept C75217442 @default.
• W2605279665 hasConcept C86554907 @default.
• W2605279665 hasConcept C86803240 @default.
• W2605279665 hasConcept C95444343 @default.
• W2605279665 hasConcept C96232424 @default.
• W2605279665 hasConceptScore W2605279665C121608353 @default.
• W2605279665 hasConceptScore W2605279665C126322002 @default.
• W2605279665 hasConceptScore W2605279665C143998085 @default.
• W2605279665 hasConceptScore W2605279665C2776256026 @default.
• W2605279665 hasConceptScore W2605279665C2778826759 @default.
• W2605279665 hasConceptScore W2605279665C2779013556 @default.
• W2605279665 hasConceptScore W2605279665C2779234561 @default.
• W2605279665 hasConceptScore W2605279665C502942594 @default.
• W2605279665 hasConceptScore W2605279665C54355233 @default.
• W2605279665 hasConceptScore W2605279665C57074206 @default.
• W2605279665 hasConceptScore W2605279665C62112901 @default.
• W2605279665 hasConceptScore W2605279665C62478195 @default.
• W2605279665 hasConceptScore W2605279665C71924100 @default.
• W2605279665 hasConceptScore W2605279665C75217442 @default.
• W2605279665 hasConceptScore W2605279665C86554907 @default.
• W2605279665 hasConceptScore W2605279665C86803240 @default.
• W2605279665 hasConceptScore W2605279665C95444343 @default.
• W2605279665 hasConceptScore W2605279665C96232424 @default.
• W2605279665 hasFunder F4320321001 @default.
• W2605279665 hasFunder F4320321540 @default.
• W2605279665 hasLocation W26052796651 @default.
• W2605279665 hasLocation W26052796652 @default.

• next